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Background: The functional role of the bladder urothelium has been the focus of much recent research. The
bladder mucosa contains two significant cell types: urothelial cells that line the bladder lumen and suburothelial
interstitial cells or myofibroblasts. The aims of this study were to culture these cell populations from human
bladder biopsies and to perform immunocytochemical characterisation.
Methods: Primary cell cultures were established from human bladder biopsies (n = 10). Individual populations of
urothelial and myofibroblast-like cells were isolated using magnetic activated cell separation (MACS). Cells were
slow growing, needing 3 to 5 weeks to attain confluence.
Results: Cytokeratin 20 positive cells (umbrella cells) were isolated at primary culture and also from patients’
bladder washings but these did not proliferate. In primary culture, proliferating cells demonstrated positive
immunocytochemical staining to cytokeratin markers (AE1/AE3 and A0575) as well fibroblasts (5B5) and smooth
muscle (aSMA) markers. An unexpected finding was that populations of presumptive urothelial and myofibroblast-
like cells, isolated using the MACS beads, stained for similar markers. In contrast, staining for cytokeratins and
fibroblast or smooth muscle markers was not co-localised in full thickness bladder sections.
Conclusions: Our results suggest that, in culture, bladder mucosal cells may undergo differentiation into a
myoepithelial cell phenotype indicating that urothelial cells have the capacity to respond to environmental
changes. This may be important pathologically but also suggests that studies of the physiological function of these
cells in culture may not give a reliable indicator of human physiology.
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Background
The urinary bladder is lined by a transitional epithelial
layer, the urothelium. For many years, the urothelium
was thought to be merely a passive barrier, preventing
egress of solutes into the bladder wall. In the last dec-
ade, it has been shown that the urothelial layer
expresses muscarinic [1-3] vanilloid [4] and purinergic
receptors [5]. Recent evidence suggests that mediators
such as nitric oxide [6], adenosine triphosphate [7] and
acetylcholine [8,9] are also released from this urothelial
layer. Changes in the urothelium have been associated
with several disorders of the lower urinary tract in man
[4,10-14]. Hence clinicians and scientists have developed
increasing interest in the morphology and function of
this complex layer. A lack of access to normal human
urothelium has hampered investigations into the patho-
physiological roles of the urinary bladder and the
changes associated with disease in humans. Most cell
culture studies have been performed using animal blad-
ders [15] where cells can be isolated from relatively
large amounts of bladder tissue.
Small amounts of human bladder tissue are obtainable
from biopsy specimens; however this imposes limits on
cell culture research. Thus human studies tend to focus
upon full thickness bladder samples obtained from open
bladder surgery [16]. These studies are unable to pro-
vide information about the functional roles of the
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tion, full thickness bladder specimens are not available
from patients with bladder dysfunctions such as inconti-
nence, because they do not generally have open bladder
surgery.
T h eb l a d d e rm u c o s ai sm a d eu po ft h eu r o t h e l i u m
with an underlying lamina propria containing myofibro-
blasts, blood vessels and nerves. The urothelium is a
multilayered transitional epithelium which displays a
regular architecture. The basal cells, situated on the
basement membrane, differentiate through a number of
intermediate cells to the highly differentiated superficial
or umbrella cells [17]. Normal human urothelial cells
a r ea b l et op r o l i f e r a t ea n dr e g e n e r a t ei nc u l t u r eb u td o
not express markers of urothelium differentiation [18].
When grown in culture, human urothelial cells form a
partially differentiated urothelium [19] indicating that in
culture urothelial cells retain the potential to undergo
cytodifferentiation [20].
Beneath the urothelial cells is a layer of interstitial
cells, which have the functional and histological charac-
teristics of myofibroblasts [21] and exhibit close connec-
t i o n st os u b u r o t h e l i a ln e r v e s[ 2 2 , 2 3 ] .T h u sr e s e a r c h e r s
have become increasingly interested in the functional
roles of both the urothelium and the adjacent
myofibroblasts.
The aims of this study were to develop a reliable cul-
ture method for use in human bladder biopsy specimens.
Specifically, we characterised the immunocytochemical
features of the urothelial and myofibroblast cell layers
during cell culture and subsequent passage. To separate
different cell types, we used a cell enrichment technique
known as magnetic activated cell separation of human
cells (MACS). This technique enables isolation of func-
tionally active cells, the isolation of rare cells and the
recovery of intact cells with minimal stress during sorting
[24]. To strengthen the characterisation of these cells, we
undertook immunocytochemical analysis of full thickness
bladder samples, taken at open surgical procedures.
Methods
Patients and specimens
Human bladder biopsies were collected from 10 patients
undergoing cystoscopic examination for asymptomatic
haematuria or previously treated low-grade bladder can-
cer. Subsequent histopathology revealed that the biop-
sies were not malignant. Macroscopically normal full
thickness segments of urinary bladder wall from 3
patients (65 to 71 years) were obtained at open opera-
tion. Bladder washings were collected at cystometry
from 9 female patients with stress urinary incontinence.
Informed consent for collection of the above specimens
was obtained, in accordance with the local hospital
human ethics committee approval.
Primary culture and preparation of cell suspensions from
biopsy specimens
Biopsies were obtained at cystoscopy from a site 2 cm
cephalic and 2 cm lateral to the left ureteric orifice.
Bladder biopsies measuring approximately 1.5 - 6 mm
3
(weight 10 - 70 mg) collected into sterile saline using
strict aseptic procedures, or into culture medium (RPMI
1640) supplemented with penicillin (100 units/ml),
streptomycin (100 μg/ml) and fungazone (0.25 μg/ml).
Immediately after collection, the mucosa was dissected
away from any underlying detrusor smooth muscle,
which was discarded together with blood vessels and
connective tissue. The dissected mucosa was washed
with media (as above, three times) and then dissociated
by digestion with trypsin-EDTA (0.25 g trypsin (1:250)
a n d0 . 3 8gE D T A )a t3 7 ° Ci n9 5 %a i r ,5 % C O 2 for 5 to
10 min.
The trypsin was inactivated with an equal volume of
growth medium at 4°C, and the digested tissue passed
through a 100 μm nylon cell strainer and the cell sus-
pension centrifuged at 428 g for 10 min at 4°C. The cell
pellet was re-suspended in growth medium (RPMI1640
supplemented with penicillin (100 units/ml), streptomy-
cin (100 μg/ml) and fungazone (0.25 μg/ml) glutamine 2
mM, HEPES Buffer 25 mM and 10% heat deactivated
foetal bovine serum). Each biopsy yielded approximately
2×1 0
5 cells. Cells were plated in 25 cm
2 flasks (Becton
Dickinson) or 96 well plates and maintained in a mini-
mum volume of culture medium for several hours at 37°
C in 95% air, 5% CO2 to encourage cell attachment.
Thereafter, further culture medium was added to ade-
quately cover the cells and changed every three days
until approximately 80% confluence was reached.
Isolation of cell populations using MACS Microbeads
Individual urothelial and fibroblast cell populations were
isolated using the MACS anti-fibroblast microbeads at
the first or second passage [25]. The enrichment proto-
col was carried out as described by the manufacturers.
Cells were passaged using trypsin-EDTA (5 min at 37°
C) and the cell suspension centrifuged at 100 g for 10
min at room temperature. The cell pellet (~10
7 cells)
was resuspended in buffer (phosphate buffered saline
(pH7.2) supplemented with 0.5% bovine serum albumin,
80 μl) and microbeads (20 μl). The resulting suspension
was incubated for 30 min at room temperature then
washed in buffer (1 ml) and centrifuged at 100 g for 10
min. The supernatant was discarded and the cell pellet
resuspended in buffer (1 ml buffer), filtered through a
30 μmn y l o nm e s ha n dl o a d e do n t ot h em a g n e t i c
separation (MS) column which was placed in a magnetic
field. Unlabeled cells were washed though the column
(3× with buffer). The column was then removed from
the magnetic field and the column washed with buffer
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purity, the labelled cells were loaded onto a new, freshly
prepared column and the process repeated. At the com-
pletion of each cell enrichment procedure, two-cell sus-
pensions were obtained: the eluted cells (urothelium)
and the bound cells (myofibroblast-like cells). The cell
suspensions were diluted in culture medium and centri-
fuged 190 g for 5 min, supernatant discarded, cell pellet
resuspended in culture medium. Each cell suspension
was cultured into 12.5 cm
2 flasks and 96 well plates
using culture media and incubation conditions as
described above.
Characterisation of superficial (umbrella) cells from
bladder washings
Bladder washing fluid was collected into a flask primed
with 100 ml of culture media (as above). The collected
solution was passed through a 100 μm mesh and dec-
anted into 50 ml centrifuge tubes before being centri-
f u g e da t4 2 8gf o r1 0m i na t4 ° C .T h es u p e r n a t a n tw a s
discarded and the cell pellet resuspended in culture
medium. This was centrifuged at 122 g for 10 min at 4°
C and the cell pellet resuspended in growth media and
cultured (as above). Trypan blue was used to examine
cell viability prior to culture.
Identification of cell populations in culture, using
immunocytochemistry
Selective primary antibodies (Table 1) were employed to
identify the cell types present in individual cultures,
using immunocytochemistry. Positive and negative con-
trols were used to confirm specificity for aSMA and
cytokeratin markers.
Culture media was aspirated from plated cells which
were then rinsed three times with wash buffer (50 mM
Tris buffered saline with 0.05% Tween 80). Cells were
fixed with absolute ethanol for 5 min then allowed to
air dry for 30 min. Cells were permeabilised with wash
buffer for 30 min at room temperature. Primary anti-
body (Table 1) was added to the cells and incubated for
1 h at 37°C followed by three rinses with wash buffer.
Envision AP polymer conjugate was added to the cells
and incubated for 30 min at 37°C followed by three
rinses with wash buffer before Fast Red chromogen
solution was added. The cells were incubated initially
for 5 min at room temperature, before a further applica-
tion of chromogen and a further 10 min incubation at
room temperature. The chromogen solution was aspi-
rated and the cells rinsed with distilled water.
Histology of full thickness bladder specimens
Macroscopically normal full thickness segments of urin-
ary bladder wall were collected into carbogenated
Krebs-Henseleit solution (composition in mM: NaCl
118, KCl 4.7, NaHCO3 25, KH2PO4 1.2, MgSO4 1.2,
CaCl2 2.5 and D-glucose 11.7), and transported immedi-
ately to the laboratory. Segments were dissected and
pinned stretched onto cork boards and fixed in Zambo-
ni’s fixative. Segments were washed three times in
DMSO followed by three washes in 0.1 M phosphate
buffered saline before being placed in 30% sucrose in
0.1 M phosphate buffered saline. Segments were sub-
merged in Tissuetek
® and frozen slowly in liquid nitro-
gen then stored at -80°C. For immunohistochemistry, 5-
7 μm thick sections were mounted onto Super Frost
Plus Slides (Menzel) and air-dried. Each slide was dou-
ble labelled with the same primary antibodies used for
cell cultures studies, using Dako Envision G/2 double
labelling kit.
Analysis
Positive immunocytochemical signals were indicated by
the presence of distinct red coloured cytoplasmic preci-
pitate at the antigen site. The immunoreactive cells
were assessed visually by phase contrast microscopy.
The positive staining was expressed as the % red cyto-
plasmic staining of the total area of growth cultures.
The results are expressed as follows: 0 (no staining
detected), + some staining (1-10% of total area of
growth with positive staining), ++ (>10 - 40% of total
area of growth with positive staining), +++ (>40 - 70%
of total area of growth with positive staining) and ++++
predominant staining (>70 - 100% of total area of
growth with positive staining).
Materials
Unless otherwise specified, all tissue culture materials
were purchased from Invitrogen and plastic ware from
Table 1 Selectivity of the individual primary antibodies used to characterise cell populations
Primary Antibody Dilution used Antibody selectivity
AE1/AE3 1:1000 Cytokeratins present in epithelial cells
A0575 1:500-1:1000 Cytokeratins present in epithelial cells
Cytokeratin 20 (CK20) 1:200 Superficial umbrella cells
a-smooth muscle actin (aSMA) 1:200 Smooth muscle, myofibroblasts and myoepithelial cells, not fibroblasts
5B5 1:100 Fibroblast and myoepithelial cells
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from Miltenyi Biotec. All antibodies, including negative
controls, were from DakoCytomation and the visualisa-
tion system was the Universal DakoCytomation EnVi-
sion System-Alkaline Phosphatase AP with Fast Red
Substrate-Chromogen and Envision Labelled Polymer,
Alkaline Phosphatase.
Results
Expression of markers in primary mucosal cell cultures
from biopsy specimens
Single cell suspensions were produced by trypsin diges-
tion of mucosal cells, with the isolated cells adhering to
the surface of the culture plate within several hours of
plating. The total cell yield varied considerably, depend-
ing on the size of the biopsy. Cells were slow to grow,
with 80% confluence obtained after 3 to 5 weeks in
culture.
In preliminary immunocytochemical studies (n = 2,
Figure 1), cells in primary culture were found to display
diverse morphologies (Figure 1A). Large spreading
umbrella-like cells were isolated early in culture, but
these cells did not proliferate. Immunostaining of cul-
tures containing these large spreading cells demon-
strated that they expressed CK20 (Figure 1B).
Other mucosal cell types proliferated strongly in pri-
mary culture and these were positive for other cytokera-
tins (AE1/AE3 and A0575 (Figure 1C). These cell
populations developed a fine network of extensions (Fig-
ure 1C) that appeared to connect one cell to another. It
was notable that these cultures were also positive for
t h es m o o t hm u s c l em a r k e raSMA and the fibroblast
Figure 1 Immunohistochemistry of cultured bladder mucosal cells. At primary culture (A, B, C) cells were counter stained to demonstrate
morphology (A). A small number of cells were large with a spreading morphology, these stained for CK20 (B). Other cells were more elongated
and branching and stained for AO575 (C). Cells were also stained after treatment with MACS beads. Cells that bound to the beads (D, E, F,
myofibroblast-like cells) were stained for 5B5 (D), AE1/AE3 (E) and aSMA (F). Cells that eluted from the beads (G, H, I, urothelial cells) were
stained for 5B5 (G), A0575 (H) and aSMA (I). (Bar = 100 μm)
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with urothelial cells.
Isolation of individual cell populations using anti-
fibroblast MACS microbeads
Anti-fibroblast MACS beads were used to separate the
myofibroblast-like cells from the urothelial cells within
the primary cultures. The resulting cultures were either
derived from cells that were eluted (anti-fibroblast nega-
tive, urothelial cells) or bound (anti-fibroblast positive,
myofibroblast-like cells).
The anti-fibroblast positive cells that were bound to
the beads displayed immunoreactivity for 5B5 (Figure
1D) as well as for the cytokeratins (AE1/AE3, Figure 1E)
and aSMA (Figure 1F). Cells that were anti-fibroblast
negative and were eluted from the columns displayed
immunoreactivity to the cytokeratin markers (A0575,
Figure 1H); these cultures also showed immunoreactivity
for 5B5 (Figure 1G) and aSMA (Figure 1I).
Because MACS treated cultures showed similarities in
immunocytochemical staining, dual labeling was performed
on both bound and eluted populations (Table 2). The anti-
fibroblast positive cells (myofibroblast-like cells) that were
bound to the beads demonstrated dual labelling for cyto-
keratin markers together with 5B5 and aSMA (Figure 2A,
B, C). Similarly, cells that were anti-fibroblast negative
(urothelial cells) that were eluted from the columns also
displayed the same pattern of dual labelling for cytokeratins
together with 5B5 and aS M A( F i g u r e2 D ,E ,F ) .
Characterisation of superficial umbrella cells from bladder
washings
The cells isolated from the bladder washings were large
spreading cells (Figure 3A) that were positive for A0575
and CK20, a marker indicative of fully differentiated
superficial umbrella cells(Figure 3B). At the time of iso-
lation the isolated umbrella cells were able to exclude
trypan blue indicating cell viability. However, similar to
the CK20-positive cells isolated from bladder biopsy
specimens, these cells did not proliferate in culture.
Immunohistochemical staining of full thickness bladder
segments
To confirm the localization of the antibodies used in
this study immunohistochemical staining was also
performed in full thickness bladder segments (Figure 4).
The urothelium demonstrated strong immunoreactivity
for the cytokeratin markers (A0575, Figure 4A and AE1/
AE3, Figure 4B). Although many of the superficial
umbrella cells were lost during processing, the remain-
ing superficial cells demonstrated immunoreactivity to
CK20 (Figure 4C). None of the urothelial cells stained
positively for aSMA (Figure 4A, B and 4C).
However, it was notable that the upper quarter of the
urothelial layer also demonstrated immunoreactivity for
the fibroblast marker 5B5 (Figure 4D). Furthermore,
there was a discontinuous layer just below the basal
urothelial cells that showed strong immunoreactivity to
aSMA (Figure 4B and 4C). In the lamina propria, the
blood vessels were easily identified by the positive
aSMA staining (Figure 4A).
Discussion
In this study we have shown that small human bladder
biopsy specimens taken from patients with non-cancer-
ous conditions can be cultured. The growth rate of the
cultures established from these bladder biopsies was
relatively slow, taking 3 to 5 weeks to reach confluence.
Bladder urothelial cells are known to be slow growing
with a previous study isolating urothelial cells from
large bladder cystectomy samples reported confluence
only being reached in 20% of cases even after 2 to 3
weeks in culture [26]. In this study the slow growth rate
is likely related to the small number of cells (approxi-
mately 2 × 10
5 c e l l si s o l a t e df r o me a c hb i o p s y )i s o l a t e d
f r o mt h eb i o p s yt i s s u es a m p l e s[ 2 7 ] .I na d d i t i o n ,o u r
cultures were established from bladder biopsies taken
from adults (age range 19 to 85) which influences the
rate of urothelial cell growth in culture [26-28].
As expected, urothelial cells cultured from biopsy
samples showed positive immunoreactivity for cytokera-
tin markers (CK20, AE1/AE3 and A0575). However, an
unexpected finding was that some cells in the culture
also demonstrated immunoreactivity for markers of
smooth muscle (aS M A ) .T h i sw a sa n o m a l o u sa si nf u l l
thickness bladder segments, aSMA staining was not
present in the urothelial layer, rather positive staining
for aSMA was seen in a sub-urothelial layer, which was
consistent with a myofibroblast layer previously shown
in urinary bladder from the pig [21]. However, this
Table 2 Characterisation of cell populations present in human bladder mucosa cultures
A0575 AE1/AE3 CK20 aSMA 5B5
Primary culture ++ (n = 2) ++ (n = 2) +++ (n = 2) ++ (n = 2) ++ (n = 2)
Anti-fibroblast eluted ++++ (n = 7) ++ (n = 5) 0 (n = 2) ++ (n = 7) +++ (n = 4)
Anti-fibroblast bound ++++ (n = 7) 0 (n = 5) 0 (n = 2) +++ (n = 5) +++ (n = 7)
The results are expressed as follows: 0 (no staining detected), + some staining (1-10% of total area of growth with positive staining), ++ (>10 - 40% of total area
of growth with positive staining), +++ (>40 - 70% of total area of growth with positive staining) and ++++ predominant staining (>70 - 100% of total area of
growth with positive staining).
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markers. This pattern of immunocytotochemical staining
of cells in culture therefore indicated that either the
urothelial cells have the potential to develop morpholo-
gical features of cells that possess contractile properties
(i.e. myoepithelial cells) or that mixed populations of
both urothelial cells and myofibroblasts from lamina
propia were present in the cultures. Mixed populations
of cobblestone and spindle shaped cells have been pre-
viously described in cultures from the urinary tract [28].
Anti-fibroblast MACS microbeads were used to isolate
individual populations of urothelial and myofibroblast-
like cells. We expected to obtain two individual popula-
tions. Firstly, a population of myofibroblast-like cells,
which were anti-fibroblast positive cells that bound to
the MACS beads and secondly, a population of urothe-
lial cells, which were anti-fibroblast negative cells that
were eluted from the beads. However, in these experi-
ments both the presumptive urothelial and myofibro-
blast-like cells were found to stain for the same markers
(AO575, 5B5 and aSMA). This could be explained if the
cells isolated had the capacity to express characteristics
of epithelial (AO575), fibroblast (5B5) and smooth mus-
cle (aSMA) cells during culture.
It is known that epithelial cells such as the urothelium
have the capacity to undergo transformation. Epithelial-
mesenchymal-myofibroblast transformation is usually
induced by growth factors e.g. TGF-b [29-33]. This
transformation is a key feature in conditions such as
organ fibrosis and wound healing [29]. These trans-
formed epithelial cells will then characteristically express
aSMA [30-32]. Such transformations are commonly
associated with injury of cell-cell junctions [31,33].
Cross and associates [20] suggested that transformation
of urothelial cells could be influenced by the culture
conditions and demonstrated the reversibility of differ-
entiation between squamous and transitional cell pheno-
type. Interestingly, previous studies have reported that
prolonged culture of urothelial cells isolated from blad-
der [26] and ureter [34] is associated with the co-expres-
sion of cytokeratins and vimentin. Vimentin is a marker
commonly used for myofibroblasts [35-38]. It could be
suggested that the changes in urothelial cells in culture
may occur due to the “damage” the cells perceive when
Figure 2 Dual labeling of MACS treated cell populations. Cells that bound to the MACS anti-fibroblast beads (myofibroblast-like cells, A, B, C)
or that were eluted from the MACS beads (urothelial cells, D, E, F) were stained with (A, D) A0575 (brown) and 5B5 (Red) (B, E) with A0575
(brown) and aSMA (Red) and (C, F) aSMA (brown) and 5B5 (Red). (Bar = 100 μm)
Figure 3 Bladder superficial urothelial cells isolated from
bladder washings. Phase contrast microscopy demonstrated large
spreading cells (A) which were positive for the umbrella cell marker
CK20 (B). (Bar = 50 μm)
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represent naturally occurring process of transdifferentia-
tion in vivo.
The expression of aSMA in cultured urothelial cells
implies that urothelial cells have the ability to acquire
contractile components given the appropriate stimulus.
One stimulus for acquisition of contractile components
c o u l db ec e l ld a m a g ei nr e s p o n s et oi n f l a m m a t i o no r
another insult. One in vivo model of urothelial cell
damage is treatment with cyclophosphamide, an irri-
tant that is excreted in the urine. Cyclophosphamide
use has been associated with the identification of actin
filaments localised to rat urothelial cells [39]. Similarly,
activation of inflammatory mast cells has been asso-
ciated with transformation of fibroblasts, as indicated
by expression of aSMA [40]. Together, these findings
could be important to our understanding of bladder
pathology, since inflammation is currently being con-
sidered as having a role in the aetiology of bladder
conditions such as interstitial cystitis [41] and the
overactive bladder [42,43].
In all cultures the isolated cells expressed cytokeratins,
as indicated by positive immunocytochemical staining
with the markers AE1/AE3 and A0575. Of interest is
the difference in the pattern of cytokeratin staining in
the anti-fibroblast positive cells. These cells stained posi-
tively for A0575 but not for AE1/AE3. The difference in
this result could be related to differences in the cytoker-
atins labelled by the different antibodies. The AE1/AE3
antibody identifies the majority of human cytokeratins
present in epithelial cells but not CK12, CK17 or CK18.
In contrast the A0575 antibody is a cocktail of low and
high molecular weight cytokeratins. The differences in
the pattern of cytokeratin staining in the anti-fibroblast
positive cells could also relate to the state of differentia-
tion of these cells as cytokeratin expression in the
urothelium alters with differentiation of urothelial cells
in culture [26,27] and with the and position within the
layers of cells making up the urothelium in vivo [44].
It is known that normal urothelium is characterised by
terminally differentiated superficial cells, which express
cytokeratin 20 [44-46]. While our early primary cultures
derived from bladder biopsies contained some cells that
were positive for CK20, this marker was soon lost in
culture. To confirm that these cells were in fact termin-
ally differentiated, superficial umbrella cells, we isolated
cells from bladder washings obtained during cystometric
testing (Figure 3). During cystometric testing the blad-
der is filled with saline in the presence of a catheter
which may dislodge some of the superficial umbrella
cells. The cells isolated from bladder washings showed
similar growth and staining patterns to the CK20 posi-
tive cells isolated from the bladder biopsy specimens.
Our finding that CK20 staining is lost with culture is in
keeping with previous work showing that in culture,
human urothelium does not undergo complete terminal
differentiation and does not express cytokeratin 20
[19,47,48].
Figure 4 Dual labelling of urothelim (Uro) and lamina propria (lp) of human bladder. Full thickness segments of human bladder were
stained with (A) the cytokeratin marker A0575 (brown) and aSMA (red) or (B) AE1/AE3 (brown) and aSMA (red). (C) with CK20 (brown) and
aSMA (red). D. Full thickness segments were stained with 5B5 (red). Sections were counterstained with haematoxylin. (Bar = 50 μm)
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In conclusion, it appears that primary cultures of
urothelial and myofibroblast-like cells from human blad-
der biopsies are quite feasible, but the cells are slow
growing, needing at least 3 weeks to attain confluence.
Our results suggest that urothelial cells in culture alter
their characteristics, so that studies of physiological
function in these cells may not give a reliable indicator
of human physiology in vivo. However, these results
demonstrating transformation of urothelial cell into a
contractile phenotype may have important implications
for understanding of bladder dysfunction.
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